2001
(2001) |
Launched cosmetics brand "Obagi".
It sparked a vitamin C boom.
|
2002
(2002) |
Launched "Rohto Eye Stretch".
Acquired MG Pharma Co., Ltd.
|
2003
(2003) |
The second factory building (skin care product factory) was completed in the Ueno Techno Center.
Launched Mentholatum Medi Quick.
|
2004
(2004) |
Launched basic skincare brand "Hada-labo."
A new symbol mark and slogan were established.
|
2005
(2005) |
Launched "Mentholatum Melano Buster (now MELANO CC)".
|
2006
(2006) |
Rohto Research Village Kyoto research center opens
Launched "OXY" as a men's skincare brand in Japan.
Launched "Wakan-sen".
|
2007
(2007) |
Acquired Meguro Kako Co., Ltd. (now Qualitech Pharma Co., Ltd., a consolidated subsidiary) and gained management rights.
Launched "50 Megumi".
|
2008
(2008) |
Tokyo branch office moves to new building.
Launched sunscreen "SKIN AQUA".
|
2009
(2009) |
Kunio Yamada becomes chairman and Toshiaki Yoshino becomes president.
Launched "Epistem".
Entered the department store sector.
|
2010
(2010) |
Tianjin Rohto Herbal Medicine Co., Ltd. (currently a consolidated subsidiary) is established in China. |
2011
(2011) |
A new "Disaster Reconstruction Support Office" has been established to support orphans of the earthquake disaster.
|
2013
(2013) |
Launched "De-O".
Shunkoku Shunsai opens in Grand Front Osaka (closed in May 2022).
Changed to "Regenerative medicine Research Planning Department, Agri-Farm Business Department."
The Grand Front Osaka office was opened in the Grand Front Osaka shopping mall in front of Osaka Station, and some of the head office functions were relocated there.
|
2015
(2015) |
Launched ROHTO V5 tablets.
Acquired shares of Mayado Pharmaceutical Co., Ltd. (making it a subsidiary).
|
2016
(2016) |
New CI “NEVER SAY NEVER” established.
Started double job within the company and challenge work outside the company.
Acquired shares in A.J. North (Pty) Ltd, in the Republic of South Africa (making it a subsidiary).
Acquired shares in OPHTHALMOS S.A., a Brazilian eye drop manufacturing and sales company (making it a subsidiary).
The Rohto Stem Cell Processing Center in Rohto Research Village Kyoto has obtained a "license to manufacture specific cell processed products."
Launched "Rohto V Premium", the first of the high-priced eye drops "V Rohto Series." |
2017
(2017) |
June 10th has been designated as Rohto Day, as certified by the Japan Anniversary Association.
Japan's first clinical trial begins for allogeneic adipose tissue-derived stem cell preparation ADR-001 for liver cirrhosis.
|
2018
(2018) |
Launched "DEOCO".
|
2019
(2019) |
We have introduced the health coin "ARUCO to support employee health promotion.
Masashi Sugimoto becomes president.
|
2020
(Reiwa 2) |
Acquired Japan Eye Drop Research Institute Co., Ltd. (currently a consolidated subsidiary) and gained management rights.
A "COVID-19 Medical Institution Support Office" has been established.
Announced the launch of a Japan-made, first-of-its-kind corporate clinical trial of Regenerative medicine using allogeneic mesenchymal stem cells for severe COVID-19 pneumonia.
|
2021
(Reiwa 3) |
Acquired shares of Olympus RMS Co., Ltd. (currently Interstem Co., Ltd., a consolidated subsidiary).
Obtained manufacturing and sales approval and launched a rapid antigen test kit for the novel coronavirus (SARS-CoV-2).
Rohto Pharmaceutical acquires shares in Amato Pharmaceutical (making it a subsidiary). |
2022
(Reiwa 4) |
New factory building C at Ueno Techno Center completed. |
2023
(Reiwa 5) |
Participated in the Fujita Health University Tokyo Advanced Medical Research Center, a next-generation medical and research hub. |
2024
(Reiwa 6) |
A laboratory and office was opened at Nakanoshima Qross (International Center for Future Medicine).
Acquired shares in Eu Yan Sang International Ltd., a Singaporean herbal medicine manufacturer and distributor.
Acquired shares in the Austrian pharmaceutical company Mono chem-pharm Produkte GmbH.
|
2025
(Reiwa 7) |
Participated in the Osaka Healthcare Pavilion at the 2015 World Exposition in Osaka, Japan (Osaka-Kansai Expo).
Hidetoshi Seki becomes president. |